Brain Aneurysm Treatments
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm.
Many factors are considered when making treatment decisions for a brain aneurysm Treatment. The size and location of the aneurysm, the presence or absence of symptoms, the patient's age and medical condition, and the presence or absence of other risk factors for aneurysm rupture are considered. In some cases, the aneurysm may not be treated and the patient will be closely followed by a doctor. In other cases, surgical treatment may be indicated.
Download sample PDF Copy Here
Large, giant and wide-necked aneurysms can be challenging to treat with traditional methods. The pipeline embolization is a new treatment option for large or giant aneurysms with wide necks. Endovascular coiling and open neurosurgical clipping only repair the aneurysm.
Several healthcare organizations and industry players are implementing constructive strategies to boost the research and development programs pertaining to the treatment of brain aneurysm. For instance, in August 2019, Fujitsu Australia, Macquarie Medical Imaging, Macquarie University, and GE Healthcare announced a new research collaboration to find advanced techniques to improve the diagnosis of brain aneurysm. The association announced the focus on utilization and adoption of artificial intelligence to identify and analyze brain aneurysms.
Other companies in this space are also focusing on collaborative efforts to introduce new technologies and medical devices for the treatment of brain aneurysm. For instance, in December 2018, Medtronic received FDA approval for its Pipeline Flex, a permanent mesh cylinder (stent) for the treatment of brain aneurysm. Additionally, in January 2020, MicroVention, Inc. got FDA approval for its FRED (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.
Endovascular coiling is a minimally invasive technique, which means an incision in the skull is not required to treat the brain aneurysm. Rather, a catheter is advanced from a blood vessel in the groin up into the blood vessels in the brain. Fluoroscopy (live X-ray) is used to assist in advancing the catheter to the head and into the aneurysm.
Once the catheter is in place, very tiny platinum coils are advanced through the catheter into the aneurysm. These tiny, soft, platinum coils, which are visible on X-ray, conform to the shape of the aneurysm. The coiled aneurysm becomes clotted off (embolization), preventing rupture. This procedure is performed either under general or local anesthesia.
Leading companies operating in the brain aneurysm treatment market are Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Mizuho Medical Co, Ltd, Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., KANEKA CORPORATION, adeor medical AG, and Evasc Medical Systems Corp among others.
Source: The Insight Partners